Fighting cancer with nanoparticles

FHS
June 27, 2024
10:10 am

Nanoparticles may be the future of the fight against pancreatic cancer, but also tumours that currently have no cure options. A video news release provides a synthesis of the ULISES project milestones.

LR-19114 by LG Chem for Diphtheria: Likelihood of Approval

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes

June 18, 2024

NIH grant funds the development of allograft-rejection-on-a-chip model

Vadim Jucaud, Ph.D., Assistant Professor at the Terasaki Institute for Biomedical Innovation, has been awarded a grant from the National Institutes of Health to develop

January 23, 2024

FDA hits Neumora with clinical hold for schizophrenia drug after preclinical data showed convulsions in rabbits

Neumora Therapeutics has hit a road block to becoming a major neuroscience player, with the FDA placing a clinical hold on a Phase 1 study

April 16, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.